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Translational Research on Atrial
Arrhythmia
Nils Bögeholz1* , Paul Pauls1,2, Dirk G. Dechering1, Gerrit Frommeyer1,
Joshua I. Goldhaber3, Christian Pott4, Lars Eckardt1, Frank U. Müller2 and
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Background: Principal mechanisms of arrhythmia have been derived from ventricular
but not atrial cardiomyocytes of animal models despite higher prevalence of atrial
arrhythmia (e.g., atrial fibrillation). Due to significant ultrastructural and functional
differences, a simple transfer of ventricular proneness toward arrhythmia to atrial
arrhythmia is critical. The use of murine models in arrhythmia research is widespread,
despite known translational limitations. We here directly compare atrial and ventricular
mechanisms of arrhythmia to identify critical differences that should be considered in
murine models for development of antiarrhythmic strategies for atrial arrhythmia.
Methods and Results: Isolated murine atrial and ventricular myocytes were analyzed
by wide field microscopy and subjected to a proarrhythmic protocol during patch-clamp
experiments. As expected, the spindle shaped atrial myocytes showed decreased
cell area and membrane capacitance compared to the rectangular shaped ventricular
myocytes. Though delayed afterdepolarizations (DADs) could be evoked in a similar
fraction of both cell types (80% of cells each), these led significantly more often
to the occurrence of spontaneous action potentials (sAPs) in ventricular myocytes.
Interestingly, numerous early afterdepolarizations (EADs) were observed in the majority
of ventricular myocytes, but there was no EAD in any atrial myocyte (EADs per cell;
atrial myocytes: 0 ± 0; n = 25/12 animals; ventricular myocytes: 1.5 [0–43]; n = 20/12
animals; p< 0.05). At the same time, the action potential duration to 90% decay (APD90)
was unaltered and the APD50 even increased in atrial versus ventricular myocytes.
However, the depolarizing L-type Ca2+ current (ICa) and Na+/Ca2+-exchanger inward
current (INCX) were significantly smaller in atrial versus ventricular myocytes.
Conclusion: In mice, atrial myocytes exhibit a substantially distinct occurrence of
proarrhythmic afterdepolarizations compared to ventricular myocytes, since they are in
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a similar manner susceptible to DADs but interestingly seem to be protected against
EADs and show less sAPs. Key factors in the generation of EADs like ICa and INCX
were significantly reduced in atrial versus ventricular myocytes, which may offer a
mechanistic explanation for the observed protection against EADs. These findings may
be of relevance for current studies on atrial level in murine models to develop targeted
strategies for the treatment of atrial arrhythmia.
Keywords: afterdepolarizations, translational research, atrial cardiomyocytes, atrioventricular differences, atrial
arrhythmia
INTRODUCTION
Triggered arrhythmia originates from early (EADs) and delayed
(DADs) afterdepolarizations on the cellular level (Damiano and
Rosen, 1984; Levine et al., 1985; January and Riddle, 1989).
Underlying molecular mechanisms and principle concepts of
proarrhythmic mechanisms have been well defined in ventricular
cardiomyocytes in various experimental models (Pogwizd et al.,
1999, 2001; Sipido et al., 2000; Pott et al., 2012). In the past
two decades, murine models have been increasingly investigated
in arrhythmia research due to their accessibility for genetic
manipulation despite significant differences between mouse and
human physiology (for review, see Nerbonne, 2014).
Yet atrial – or in clinical terms supraventricular – arrhythmias
are much more prevalent than ventricular arrhythmias and
attract great attention in clinical and translational research,
especially in the case of atrial fibrillation (Kirchhof et al., 2016).
However, the electrophysiological properties and underlying
molecular mechanisms in atrial cardiomyocytes are considerably
less defined as compared to ventricular cardiomyocytes,
especially in smaller rodents like mice and rats (Walden et al.,
2009). Nevertheless, murine models are frequently used to
investigate proarrhythmic substrates or to evaluate potential
antiarrhythmic strategies to counter atrial arrhythmia even on
multicellular or whole-heart level (Bao et al., 2016; Syeda et al.,
2016; Wan et al., 2016; Chang et al., 2017; Wang et al., 2017). Yet,
there is a lack of studies, which directly compare proarrhythmic
substrates and their molecular basis in atrial versus ventricular
cardiomyocytes of murine models, which appears unexpected in
the face of the high clinical and translational relevance of atrial
arrhythmia and the widespread use of murine models in the
research of atrial arrhythmia.
One might suppose that ventricular proneness toward
proarrhythmic afterdepolarizations can simply be applied on the
atrial level. However, this requires a consistent functional and
structural analogy between atrial and ventricular cardiomyocytes,
which is not the case. Previous work demonstrated substantial
differences regarding the morphology and microarchitecture of
atrial and ventricular cardiomyocytes (Bossen et al., 1981; Blatter
et al., 2003; Brette et al., 2005; Walden et al., 2009; Bootman et al.,
2011; Frisk et al., 2014). Thus, atrial myocytes rather resemble
smooth-muscle myocytes due to the diminished sarcomere
structure and a fusiform shape. Also, t-tubules as a morphologic
feature of crucial functional relevance for excitation–contraction
coupling in ventricular myocytes are substantially reduced or
even absent in a major fraction of atrial myocytes (Brette et al.,
2005; Frisk et al., 2014), though this is species-dependent (Yue
et al., 2017). This again leads to a considerably altered excitation
pattern consisting of a slowly propagating centripetal wave in
atrial myocytes as compared to the rapid simultaneous and
homogenous excitation pattern in ventricular myocytes (Blatter
et al., 2003). In addition, there are considerable differences in the
expression of functional key proteins participating in excitation–
contraction coupling (Boknik et al., 1999; Lüss et al., 1999,
2000; Walden et al., 2009; Nerbonne, 2014). Consequently, these
findings suggest significant structural and functional differences
and absence of a perfect analogy of both cell types. Moreover,
these atrioventricular differences depend on the investigated
species. For instance, the t-tubule system in atrial myocytes is
reportedly poorly developed in rats, cats, rabbits, and guinea
pigs, but well developed in mice or larger mammals like
humans (Yue et al., 2017). Likewise, atrioventricular differences
in the expression of critical Ca2+ handling proteins are species-
dependent (Lüss et al., 1999).
The diverse ultrastructure and ion channel expression are
reflected in the differing action potential kinetics between atrial
and ventricular myocytes in mammals. In general, the resting
membrane potential of atrial myocytes is more depolarized as
compared to ventricular myocytes, which may be a result of
a decreased IK1 function in atrial myocytes (Cordeiro et al.,
2015). Both, the upstroke velocity and the amplitude of the
atrial action potential are decreased in comparison to ventricular
myocytes (Grandi et al., 2011), which is promoted by the
depolarized resting potential in atrial myocytes that leads to
a slower and more incomplete recovery from inactivation of
the cardiac sodium channels. Early repolarization in phase 1 is
enhanced in atrial myocytes due to the synergistic activation of
the transient K+ currents Ito(f) and atrial-specific IKur in atrial
myocytes (Nerbonne and Kass, 2005). The voltage-level of the
action potential plateau in phase 2 is more hyperpolarized in
atrial myocytes due to a higher cumulative driving force of
repolarizing Kv populations. Differences in the action potential
duration (APD) seem to be species-dependent, but in higher
mammals, the atrial action potential is abbreviated (Burashnikov
et al., 2014).
When compared to human action potentials, typical murine
ventricular action potentials are significantly abbreviated and
exhibit a short plateau phase that starts at more negative voltage
levels (Ahrens-Nicklas and Christini, 2009). A large Ito in murine
myocytes outweighs the depolarizing ICa and therefore reduces
the plateau voltage level, whereas the human Ito is less dominant.
Taken together, electrophysiological parameters differ between
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atrial and ventricular myocytes and between different species, as
reflected in the characteristic referring action potential shapes.
To account for the significant atrioventricular differences,
some recent studies applied computational approaches to mimic
atrial electrophysiology to investigate mechanisms of atrial
arrhythmia (Zhang et al., 2005; Maleckar et al., 2009; Grandi
et al., 2011; Ni et al., 2017). However, despite great advancement
during the past decade, computational models are based on
assumptions and thus still differ from the genuine atrial
electrophysiology, which might particularly apply to complex and
stochastic parameters like proarrhythmic afterdepolarizations or
atrial fibrillation, that result from a multitude of underlying
processes and interactions.
Since murine models are frequently used in translational
research on atrial arrhythmia, but data on the manifestation of
proarrhythmic afterdepolarizations in atrial myocytes and their
differences to ventricular myocytes is sparse, we investigated
afterdepolarizations and their molecular bases in atrial and
ventricular myocytes in a murine model. The obtained findings
might carry several implications for contemporary and future
studies investigating atrial arrhythmia in murine models.
MATERIALS AND METHODS
Genetic Background of the Murine Model
Investigated wild-type mice were on a combined genetic
background (CD-1 and C57BL/6) as previously described
(Bögeholz et al., 2015, 2016) at the age of 7.5–12.5 weeks. The
applied experimental methods confirmed to the instructions
of Directive 2010/63/EU of the European Parliament on
the protection of animals used for scientific purposes and
were approved by the local authorities (Landesamt für Natur,
Umwelt und Verbraucherschutz NRW; permission number:
84-02.05.50.17.002).
Isolation of Atrial and Ventricular
Cardiomyocytes
The methods to isolate atrial and ventricular cardiomyocytes have
been reported in former studies (Bögeholz et al., 2016, 2017). In
brief, mice were euthanized by carbon dioxide inhalation and
excised hearts were retrogradely perfused via the aorta using
a modified Langendorff apparatus. For isolation of ventricular
myocytes, hearts were perfused for 6 min ± 15 s on 37◦C
with a perfusion solution containing (in mM): NaCl 113, KCl
4.7, KH2PO4 0.6, Na2HPO4 0.6, MgSO4 1.2, NaHCO3 12,
KHCO3 10, taurine 30, HEPES 10, glucose 11.1, BDM 10, heparin
14.3 IE/ml, collagenase type II 190 units/ml (Worthington
Biochemical Corporation), protease from streptomyces griseus
type XIV 0.5 units/ml (Sigma Aldrich), pH = 7.4. Ventricular
tissue was dissected below the atrioventricular valves to avoid
contamination of the ventricular cell suspension by atrial
myocytes. Enzymatic degradation was inhibited by application
of new born calf serum and Ca2+ was supplemented gradually
to 1 mM. To isolate atrial cardiomyocytes, hearts were perfused
for 3 min with a perfusion solution containing (in mM): NaCl
136, KCl 5.4, CaCl2 0.2, MgCl2 1, Na2HPO4 0.33, HEPES 5, and
glucose 11.1, pH = 7.4. Then, a Ca2+ depleted perfusion solution
was applied for 3 min, followed by enzymatic degradation of the
conjunctive tissue for 21 ± 5 min by a Ca2+ containing solution
with collagenase type II (90 U/mL), bovine serum albumin
(1 mg/ml), CaCl2 (26.7 nM) and taurine (20 mM). Atria were
cut above the atrioventricular valves prior to tissue disruption.
Similar to ventricular myocytes, enzymatic degradation was
inhibited by new born calf serum and Ca2+ was supplemented
to a final concentration of 12.5 µM. Atrial myocytes were kept in
the following cooled storage solution (in mM): KCl 25, KH2PO4
10, L-aspartic acid potassium salt 10, L-glutamic acid potassium
salt 100, MgSO4 2, taurine 20, EGTA 0.5, creatine 5, HEPES 5,
glucose 20, bovine serum albumin 1 mg/ml, pH = 7.2.
Two-Dimensional Planimetric Cell Area
Quantification of the two-dimensional planimetric cell area was
performed in suspensions of non-fixed atrial and ventricular
myocytes using a Photometrics CoolSNAP HQ2 camera on
a Nikon eclipse TI-E microscopy system. Quantification was
performed with the NIS-Elements AR v. 4.13.05 (Nikon) imaging
software.
Cellular Electrophysiology
For whole-cell patch-clamp experiments, cells were transferred
to the stage of an inverted microscope (IX 50, Olympus)
and investigated using an EPC 800 amplifier connected to
an InstruTECH ITC-18 interface and a MS computer with
the PatchMaster v2x53 software (all HEKA, Bellmore, NY,
United States) (Bögeholz et al., 2015, 2016). The tip resistance
of patch pipettes (GB150TF-8P, Science Products, Hofheim,
Germany) was 4± 1 M.
Current-clamp measurements were conducted in the
perforated patch configuration using amphotericin B (281 µM).
The basal extracellular solution contained (in mM): NaCl 136,
NaH2PO4 0.33, KCl 5.4, CaCl2 1.0, MgCl2 1.0, HEPES 10,
Glucose 11.1, pH = 7.4. During the protocol, isoproterenol
(1 µM) was applied via a rapid extracellular perfusion system.
The intracellular solution contained (in mM): NaCl 5.0, KCl 90.0,
KOH 35.0, EGTA 1.0, MgATP 2.5, HEPES 5.0, pH = 7.4.
For voltage-clamp measurements of the voltage-gated L-type
Ca2+ current (ICa), the ruptured patch configuration was used.
Activation of the voltage-gated Na+ current was prevented by
using a holding potential of −40 mV. ICa was elicited via
depolarizing square wave pulses ranging from −30 to +40 mV
each lasting for 400 ms. The following solutions were used
(in mM): extracellular: NaCl 136.0, KCl 5.4, HEPES 10.0,
MgCl2 1.0, NaH2PO4 0.33, CaCl2 1.0, Glucose 11.1, pH = 7.4.
Intracellular: CsCl 120.0, TEA-Cl 10.0, NaCl 10.0, HEPES 20.0,
MgATP 5.0, cAMP 0.05, pH = 7.2.
To measure the Na+/Ca2+-exchanger inward current (INCX),
cells were held at −80 mV and depolarized three times to
+10 mV. After 10 s of rest, the cells were rapidly perfused with
caffeine (10 mM). Extracellular solution contained (in mM):
NaCl 140, KCl 4, HEPES 10, MgCl2 1, BaCl2 0.1, 4-amino
pyridine 5, glucose 11.1, CaCl2 1, pH = 7.4. Intracellular solution
contained (in mM): EGTA 0.02, GTP-Tris 0.1, K-aspartate 92,
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KCl 48, HEPES 10, MgATP 1, Na2ATP 4, pH = 7.2. Measurements
were not corrected for liquid junction potentials (−3.3 mV,
calculated with Clampex 9.2.1.9, Molecular Devices, San Jose,
CA, United States).
Statistical Analysis
Numerical data are given as means± standard error of the mean
(SEM), or in case of non-normal distributed data, as the median
value with the interquartile range (IQR) between the 25th and
75th percentile (Q3–Q1). In box plot figures, the boxes represent
the data between 25th and 75th percentile, whiskers data between
the 10th and 90th percentile, horizontal lines give the median
value, whereas the mean value is shown by the small square.
For direct comparison between atrial and ventricular myocytes,
the unpaired two-tailed Student’s t-test or the Mann–Whitney
Rank Sum test was performed, where appropriate. Repeated
measurements were analyzed using a two-way repeated measures
ANOVA test followed by a Holm–Sidak post hoc test. Proportions
were compared with a Fisher’s exact test. P-values < 0.05 were
considered statistical significant.
RESULTS
Reduced Cell Area and Cell Capacitance
in Murine Atrial Versus Ventricular
Myocytes
Murine atrial myocytes exhibited a fusiform shape and reduced
cross-striation in contrast to the rectangular shaped clearly
striated ventricular myocytes in microscopic images (Figure 1A).
The planimetric cell area was significantly smaller in atrial
compared to ventricular myocytes (planimetric cell area in
µm2; atrial myocytes: 1227 [982–1574]; n = 154/4 cells/animals;
ventricular myocytes: 2852 [2282–3808]; n = 208/4 cells/animals;
p< 0.05) (Figure 1B). Consistently, the electrical cell capacitance
as a measure for cell size was smaller in atrial myocytes compared
to ventricular myocytes (electrical cell capacitance in pF; atrial
myocytes: 73.8 ± 3.3; n = 49/18 cells/animals; ventricular
myocytes: 131.6 ± 3.9; n = 54/19 cells/animals; p < 0.05)
(Figure 1C).
No Protective Action Potential
Shortening in Murine Atrial Myocytes
Action potential kinetics were evaluated during 1 Hz pacing
after establishing steady state conditions at room temperature
(22 ± 2◦C) (Figure 2A). The resting membrane potential
was significantly hyperpolarized in ventricular myocytes when
compared to atrial myocytes (resting membrane potential in
mV; atrial myocytes: −65.7 [−68.0 to −63.6]; n = 25/12
cells/animals; ventricular myocytes: −68.4 [−71.9 to −65.3];
n = 20/12 cells/animals; p < 0.05) (Figure 2B). The maximum
upstroke velocity (Vmax) of the action potential as a measure of
INa availability was increased in ventricular vs. atrial myocytes
(Vmax in V/s; atrial myocytes: 57 ± 4.2; n = 25/12 cells/animals;
ventricular myocytes: 92.8 ± 5.4; n = 20/12 cells/animals;
p < 0.05) (Figure 2C). Also, the amplitude of the action
potential was increased in ventricular myocytes (action potential
amplitude in mV; atrial myocytes: 90.9 ± 2.4; n = 25/12
cells/animals; ventricular myocytes: 114.4 ± 3.7; n = 20/12
cells/animals; p < 0.05) (Figure 2D). The APD was quantified
as time to 50 and 90% decay (APD50 and APD90). APD50
was significantly prolonged in atrial myocytes (APD50 in
ms; atrial myocytes: 11.3 [7.7–13.8]; n = 25/12 cells/animals;
ventricular myocytes: 6.2 [3.8–7.6]; n = 20/12 cells/animals;
p < 0.05) (Figure 2E). Six of 20 ventricular myocytes exhibited
ongoing EADs mediating a substantial and simultaneously
unstable prolongation of the APD90 measured in these myocytes
(Figure 2F). Even when including those cells with EADs in
the analysis, APD90 was not statistically different between atrial
and ventricular myocytes (APD90 in ms; atrial myocytes: 55.3
[42.4–73.9]; n = 25/12 cells/animals; ventricular myocytes: 79.2
[34.2–212.8]; n = 20/12 cells/animals; p > 0.05) (Figure 2F).
Since EAD-deformed action potentials cannot be considered
as normal action potentials, they were then excluded from the
analysis, again resulting in no difference in APD90 between
both cell types (APD90 in ms; atrial myocytes: 55.3 [42.4–73.9];
n = 25/12 cells/animals; ventricular myocytes: 49.3 [23.6–80.7];
n = 14/10 cells/animals; p > 0.05). Representative recordings
of an atrial and ventricular action potential as well as a
ventricular action potential deformed by an EAD are presented
in Figure 2A.
Reduced Translation of DADs Into
Spontaneous Action Potentials in Atrial
Myocytes
The susceptibility toward proarrhythmic afterdepolarizations
was evaluated in atrial and ventricular myocytes using the same
provocation protocol for both cell types, comprised of abrupt
changes between various pacing frequencies and isoproterenol
application as established previously with minor modifications
(Bögeholz et al., 2015, 2016). In detail, the protocol consisted of
20 stimuli per cycle at 5 Hz; 2 Hz, 1 Hz; 0.5 Hz; 0.25 Hz, and
0.125 Hz followed by 3 min rest. Finally, 1 µM isoproterenol
was added during steady-state 1 Hz pacing (1 min.) followed
by 20 stimuli at 5 Hz, 2 Hz, 1 Hz, and 0.5 Hz resulting
in a total protocol duration of 10 min and 28 s. Delayed
afterdepolarizations (DADs) were defined as low-amplitude
depolarizations exceeding the diastolic membrane potential for
more than 2 mV (Figure 3A). Spontaneous action potentials
(sAPs) defined as fully developed action potentials arising
from a DAD and exceeding −10 mV threshold, were counted
(Figure 3A).
The fraction of cells exhibiting DADs was similar in both cell
types (fraction of cells with DADs in %; atrial myocytes: 80.0;
n = 25/12 cells/animals; ventricular myocytes: 80.0; n = 20/12
cells/animals; p > 0.05) (Figure 3B). sAPs occurred in both cell
types, but the fraction of cells with sAPs was significantly higher
in ventricular myocytes (fraction of cells with spontaneous AP
in %; atrial myocytes: 12.0; n = 25/12 cells/animals; ventricular
myocytes: 70.0; n = 20/12 cells/animals; p < 0.05) (Figure 3C).
The median number of sAPs per cell was significantly decreased
in atrial versus ventricular myocytes (Figure 3D).
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FIGURE 1 | Basic differences in morphometry between atrial and ventricular myocytes. (A) Exemplary microscopic images demonstrate morphological differences
between murine atrial and ventricular myocytes. Atrial myocytes exhibit a smaller 2D cell area compared to ventricular myocytes (B) and consistently a reduced
electrical cell capacitance (C). ∗p < 0.05 atrial vs. ventricular.
Absence of Early Afterdepolarizations in
Atrial Myocytes
Throughout the above stated protocol, the occurrence of
early afterdepolarizations (EADs) was quantified in atrial and
ventricular myocytes. EADs were defined as re-upstrokes of
the membrane potential during repolarization of a stimulated
action potential, if the membrane potential of the action potential
plateau shortly falls of and then exceeds −40 mV threshold
(Figure 4A). EADs showed various shapes as illustrated in
Figure 4A.
Under the experimental conditions chosen, no EAD occurred
in any atrial myocyte, whereas EADs occurred frequently in
ventricular myocytes. In detail, the majority of ventricular
myocytes exhibited EADs (fraction of cells with EADs in %;
atrial myocytes: 0; n = 25/12 cells/animals; ventricular myocytes:
65.0; n = 20/12 cells/animals; p < 0.05; median number of EADs
per cell; atrial myocytes: 0.0; n = 25/12 cells/animals; ventricular
myocytes: 1.5 [0.0–42.8]; n = 20/12 cells/animals; p < 0.05)
(Figures 4B,C). The median voltage take-off potential for EADs
was−44.8 mV [−51.6 to−42.2].
Reduced L-Type Ca2+ Current in Murine
Atrial Myocytes
To further investigate the molecular mechanisms of EAD and
DAD, the depolarizing L-type Ca2+ current (ICa) was measured
in atrial and ventricular myocytes (Figure 5A). To account for
differences in cell size, peak ICa was normalized to the cell
capacitance as a measure of cell surface area.
ICa peak amplitude was significantly reduced in atrial
myocytes as compared to ventricular myocytes (peak amplitude
of ICa in response to a square wave pulse to +10 mV in
pA/pF; atrial myocytes: 2.6 [2.0–3.1]; n = 13/3 cells/animals;
ventricular myocytes: 8.2 [5.7–11.0]; n = 20/4 cells/animals;
p < 0.05) (Figures 5B,C). Inactivation of ICa was estimated
by fitting a single exponential decay function to ICa tracings
in response to a voltage step to +10 mV. ICa inactivation
was unaltered between both cell types (τ in ms; atrial
myocytes: 27.7 ± 2.2; n = 13/3 cells/animals; ventricular
myocytes: 26.2 ± 1.4; n = 20/4 cells/animals; p > 0.05)
(Figure 5D).
Smaller NCX Inward Current but
Increased SR Ca2+ Load in Atrial Versus
Ventricular Myocytes
The depolarizing NCX inward current (INCX; extrusion of 1 Ca2+
from the cell in exchange for 3 Na+) is thought to promote the
occurrence of EAD and DAD. Thus, INCX was investigated in
atrial and ventricular myocytes.
INCX peak amplitude was significantly decreased in atrial
compared to ventricular myocytes (INCX amplitude in pA/pF;
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FIGURE 2 | Distinct action potential kinetics in atrial versus ventricular myocytes. (A) Representative action potentials in atrial (left) and ventricular cardiomyocytes
without (mid) and with (right) an EAD. Atrial myocytes exhibited a depolarized resting membrane potential (RMP) (B), a decreased maximal action potential (AP)
upstroke velocity (Vmax) (C), a decreased AP amplitude (D), and prolonged action potential duration to 50% decay (APD50) (E). (F) Though a fraction of ventricular
cells exhibited incessant EADs leading to AP prolongation (raw values within the dashed box), the average APD90 was unaltered between both cell types. ∗p < 0.05
atrial vs. ventricular; n.s., non-significant.
atrial myocytes: −0.40 [−0.44 to −0.18]; n = 11/3 cells/animals;
ventricular myocytes: −0.50 [−0.81 to −0.44]; n = 14/3
cells/animals; p < 0.05) (Figures 6A,B). The area above the
curve (AAC) of the inward current up to baseline (Figure 6A)
is considered as a measure for the sarcoplasmic Ca2+ content.
AAC was larger in atrial than ventricular myocytes (AAC of INCX
in pA∗s; atrial myocytes: 293 [139–574]; n = 11/3 cells/animals;
ventricular myocytes: 118.0 [98–232]; n = 14/3 cells/animals;
p< 0.05) (Figure 6C).
DISCUSSION
The use of murine models is widespread in experimental
research, due to facilitated accessibility to genetic manipulation,
short reproduction cycles and comparable low housing and
breeding costs. Hence, many experimental findings that describe
molecular mechanisms of arrhythmia, originate from single
cell experiments in murine models. However, the translational
value of findings derived from murine models is often called
into question (Kaese and Verheule, 2012; Bögeholz et al.,
2014; Nerbonne, 2014), since major electrophysiological
properties differ considerably between humans and mice.
Furthermore, the majority of proarrhythmic mechanisms
were derived from ventricular murine cardiomyocytes,
despite the higher prevalence of atrial arrhythmia and
the enormous clinical attention toward supraventricular
arrhythmia, such as atrial fibrillation. This might be due to
the robustness and ease of isolation of ventricular myocytes
facilitating experimental approaches to investigate the cellular
Frontiers in Pharmacology | www.frontiersin.org 6 August 2018 | Volume 9 | Article 933
fphar-09-00933 August 20, 2018 Time: 12:5 # 7
Bögeholz et al. Atrioventricular Differences in Proarrhythmic Afterdepolarizations
FIGURE 3 | DADs and spontaneous action potentials (sAPs) in atrial and ventricular cardiomyocytes. (A) Representative tracings with a stimulated action potential
(stim) of atrial (upper panel) and ventricular (lower panel) myocytes exhibiting DADs in the resting period. Ventricular cells did also exhibit translation of DADs into
sAPs. While the fraction of cells with DADs was unaltered (B), the fraction of cells with sAPs (C) and the average number of sAPs per cell (D) was increased in
ventricular compared to atrial myocytes. ∗p < 0.05 atrial vs. ventricular.
electrophysiology. However, due to ultrastructural and functional
differences between ventricular and atrial cardiomyocytes
the proneness toward proarrhythmic afterdepolarizations
might differ between both cell types. Consequently, in
face of these atrioventricular differences, several studies
investigated murine models, particularly on the atrial level,
using isolated cardiomyocytes (Lemoine et al., 2011; Faggioni
et al., 2014), multicellular preparations (Bao et al., 2016;
Syeda et al., 2016) and whole-heart approaches (Wan et al.,
2016; Chang et al., 2017; Wang et al., 2017) to evaluate
translational concepts in the generation of atrial fibrillation.
We here present direct evidence that the manifestation of
proarrhythmia in the form of the occurrence of EAD and DAD
considerably differs between atrial and ventricular murine
myocytes, which carries several potential implications for
arrhythmia research in murine models, especially on the atrial
level.
Protection Against EADs in Atrial
Myocytes
In line with previous studies on rats (Walden et al., 2009),
murine atrial myocytes were significantly smaller and exhibited
a fusiform shape with reduced cross-striation as compared to
the larger and rectangular ventricular myocytes. The applied
provocation protocol in our study was sufficient to elicit frequent
DADs and several sAPs in both cell types. However, though
the majority of ventricular myocytes exhibited frequent EADs,
no single EAD occurred in any investigated atrial myocyte.
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FIGURE 4 | Occurrence of EADs in ventricular but not atrial cardiomyocytes. (A) Representative tracings show various shapes of EADs in ventricular myocytes (red
tracing) when the membrane potential of the plateau first falls short of and then exceeds –40 mV threshold. The EAD waveforms ranged between a spike-like shape
(left) and a prolonged slew rate (right). No EADs occurred in any atrial myocyte (black tracing). The majority of ventricular cells (B) exhibited multiple EADs (C).
∗p < 0.05 atrial vs. ventricular.
Consistently, other studies found that genetic or pharmacological
interventions that prolong the APD are required to elicit EADs
on atrial level in murine models (Li et al., 2009; Qin et al.,
2012). However, these findings were not compared to ventricular
myocytes. The observed protection against EADs in this study
is not a result of an abbreviated action potential, because
APD90 only tended to be increased in ventricular myocytes
due to a fraction of cells that exhibited EADs (Figure 2F),
but overall, the APD90 was not statistically different between
both cell types. APD50 was prolonged in atrial myocytes, but
this likely does not promote EADs, since EADs typically occur
at a voltage below the level reached at APD50. The findings
with regard to the APDs are in good accordance with previous
findings from our group when comparing data from FVB/N
wild-type controls, published recently in two separate studies,
demonstrating APD50 values of 8.75 ± 0.8 ms and 4.6 ± 0.5 ms
and APD90 values of 38.7 ± 2.7 ms and 32.5 ± 4.4 ms for atrial
(Seidl et al., 2017) and ventricular (Schulte et al., 2016) myocytes,
respectively. Of note, these findings on the action potential
kinetics of atrial and ventricular myocytes do not apply to
higher mammals or even human action potential kinetics, since
human atrial cardiomyocytes exhibit a substantially prolonged
action potential plateau (APD90 ∼ 300 ms) (Christ et al., 2016).
Likewise, the human ventricular action potential is considerably
prolonged as compared to mouse models (APD90 ∼ 450–500 ms)
(Johnson et al., 2018). These action potential kinetics may
allow EADs in human atrial myocytes rather than in murine
atrial myocytes. Nonetheless, vigorous provocation conditions
like strong inhibition of repolarizing K+ channels, resulting
in a significant APD prolongation, is required to elicit EADs
in human atrial myocytes (Olson et al., 2006). If the APD
is prolonged by vigorous pharmacological interventions, EADs
can even be elicited in murine atrial trabeculae (Zhou and
Liu, 1995). Hence, the protection against EADs in murine
atrial myocytes can be overridden by aggressive pharmacological
interventions. However, murine atrial myocytes are still less
susceptible to EADs as compared to ventricular myocytes, which
is of relevance for studies on atrial arrhythmia using murine
models.
What is the underlying mechanism of protection against
EADs in murine atrial myocytes? Since the classical mechanism
in the generation of an EAD consists of a reactivation of ICa
or enhanced NCX-mediated inward current (Volders et al.,
1997), the prominent reduction of both, as observed in this
study, suggests a plausible explanation for the protection against
EADs in atrial myocytes. Beyond that, ICa and INCX may be
functionally coupled. Our group has shown that the reduced
NCX function in murine ventricular myocytes of homo- and
heterozygous NCX knockout mouse models is accompanied by
a reduction of ICa (Pott et al., 2007; Bögeholz et al., 2015).
In ventricular myocytes, the underlying mechanism seems to
consist of an increased subsarcolemmal Ca2+ concentration
due to reduced NCX-mediated Ca2+ extrusion capacitance,
which enhances Ca2+-dependent inactivation of ICa. Thus, the
inhibitory interaction between INCX and ICa may synergistically
protect against the occurrence of EADs. The same mechanism
could apply to atrial myocytes, although this needs to be further
investigated, since the functional coupling of INCX and ICa may
be different in atrial myocytes due to a diverse ultrastructure.
However, there may be also differences in other depolarizing
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FIGURE 5 | Reduced L-type Ca2+ current (ICa) in atrial versus ventricular myocytes. (A) Original tracings of ICa in atrial (upper panel) and ventricular (lower panel)
myocytes. The applied stimulation protocol is depicted by the inset scheme. ICa was significantly reduced in atrial compared to ventricular myocytes over a voltage
range between –10 mV and +40 mV as shown in the I–V-curve representing the mean values (B). (C) Median values of ICa peak amplitude in response to a voltage
step to +10mV. (D) ICa inactivation kinetics were unaltered between both cell types. ∗p < 0.05 atrial vs. ventricular [two-way repeated measures ANOVA for (B)].
and repolarizing ion currents that may reduce the proneness
toward EADs in atrial myocytes. Recently, Edwards et al.
(2014) proposed a role for non-equilibrium sodium current
(INa) reactivation in the generation of EADs in mice, based
on the much faster action potential repolarization velocity in
comparison to higher mammals. A role for INa reactivation is
also likely in our study since the median take-off potential of
EADs in ventricular myocytes was −44.8 mV, which is below
the ICa activation range. Though we did not directly measure
INa kinetics in our study, the reduced maximal action potential
upstroke velocity and the reduced action potential amplitude in
atrial vs. ventricular myocytes are both indicators for a reduced
Na+ channel availability. One possible cause is the relatively
depolarized resting membrane potential in atrial myocytes, which
will reduce the availability of Na+ channels and driving force for
INa in atrial versus ventricular myocytes. Furthermore, Edwards
et al. (2014) demonstrated that INa reactivation enhances with
increasing velocity of repolarization. Since atrial myocytes had
a rather triangular action potential shape along with increased
APD50, the reduced repolarization velocity in atrial versus
ventricular myocytes may thus additionally contribute to the
protection against EADs in murine atrial myocytes. Interestingly,
in their study Edwards et al. (2014) also demonstrated in a
computational model that ablation of INCX was able to eliminate
EADs and that ICa was also reactivated to a small extent during
EADs secondary to INa. Thus, the reduction of both currents
in atrial myocytes should contribute to the reduced propensity
to EADs in atrial mouse cardiomyocytes as observed in our
study.
DADs and Spontaneous Action
Potentials in Atrial Versus Ventricular
Myocytes
Both atrial and ventricular myocytes exhibited frequent DADs
on average in 4 out of 5 (80%) cells during the applied
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FIGURE 6 | Caffeine-induced NCX inward current (INCX) in atrial versus ventricular myocytes. (A) Original tracings of caffeine-induced NCX inward current (INCX) in
atrial (upper panel) and ventricular (lower panel) cells. (B) INCX amplitude in response to caffeine was significantly reduced in atrial versus ventricular myocytes.
(C) Integrated INCX from the area above the current curve (pink colored area). ∗p < 0.05 atrial vs. ventricular.
provocation protocol, which contains abrupt changes in pacing
cycle lengths and additional catecholaminergic stimulation.
Hence, the conditions were sufficient to elicit proarrhythmia
in both cell types. Since DADs result from spontaneous Ca2+
release from the sarcoplasmic reticulum (SR), the observed
increase of SR Ca2+ load as assessed by the integrated NCX
inward current in atrial compared to ventricular myocytes
may promote the occurrence of DADs in atrial myocytes.
An increased SR Ca2+ load of atrial compared to ventricular
myocytes in smaller rodents has been demonstrated previously
(Walden et al., 2009). However, the occurrence of sAPs as
the final proarrhythmic consequence of DADs was significantly
reduced in atrial compared to ventricular myocytes. This
finding might be surprising at first sight, since the resting
membrane potential in atrial myocytes is more depolarized
as compared to ventricular myocytes, which should facilitate
the translation of DADs in sAPs. However, INCX peak current
as the key translator of spontaneous Ca2+ release events
into sAPs is significantly reduced in atrial myocytes, which
could potentially explain for the reduced occurrence of sAPs
in atrial myocytes. Next to the reduced INCX peak current,
two potential alternative alterations may protect against the
occurrence of afterdepolarizations in atrial myocytes. These could
be a reduced availability of INa and/or increased repolarization
reserve. Although these components were not directly measured,
the upstroke velocity of the action potential is slowed in
atrial versus ventricular myocytes, which can be considered
as a proxy measure for reduced INa as the final translator
of INCX mediated membrane depolarization into a sAP. This
may also be a result of the depolarized resting membrane
potential in atrial myocytes. In principle, atrial myocytes could
also be protected against afterdepolarizations by an increased
repolarization reserve potentially mediated via increased IK1.
However, since IK1 is the major hyperpolarizing current in
diastole and the resting membrane potential is depolarized in
atrial myocytes, the latter possibility seems less likely. Not at
least, the substantially diverse ultrastructure of the SR and its
altered coupling to the plasma membrane may also contribute
to the reduced translation of DADs into sAPs (Frisk et al.,
2014).
Translational Perspective on Murine
Models in Research on Atrial Arrhythmia
Early and delayed afterdepolarizations are thought to promote
the occurrence of human atrial arrhythmia, such as atrial
fibrillation (Patterson et al., 2006; Beavers et al., 2013). Mice
are commonly used as models for the investigation of basic
proarrhythmic mechanisms and therapeutic strategies for
treatment of atrial fibrillation. Thus, it is of relevance to
characterize cellular proarrhythmic substrates like EADs
and DADs and existing specific differences between atrial
and ventricular myocytes in the mouse. Our findings show
that the occurrence of EADs, DADs, and sAPs significantly
differs between atrial and ventricular myocytes. Thus,
proarrhythmia in both cell types cannot be considered equal.
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Thus, a direct translation of the ventricular proarrhythmia
to the atrial level is questionable. Although basic causes for
afterdepolarizations (i.e., INCX and reactivation of ICa and INa)
might be similar, the relative quantitative contribution and
their functional interaction seem to differ in an environment
of a diverse expression of other ion channel populations
and the referring cellular microarchitecture. Together, these
differences finally result in the distinct probability for the
occurrence of afterdepolarizations in atrial and ventricular
myocytes. This finding is of relevance for the evaluation of
antiarrhythmic strategies targeting atrial arrhythmia at least
when using murine models on the single cell and multicellular
level. However, it is debatable, how good the current data
situation actually is regarding a direct comparison of atrial and
ventricular proarrhythmia in other species – particularly in
humans, which is complicated by the availability of material
to examine. In view of this limited availability – especially
of human myocardial tissue – computational modeling of
atrial electrophysiology is a promising alternative approach,
but its reliability strongly depends on the completeness
of the integrated data derived from experimental research
(Grandi et al., 2010; Bers and Grandi, 2011; Pandit et al.,
2011). There are computational models of human atrial
myocytes that simulate physiological and pathophysiological
conditions in terms of chronic atrial fibrillation based on
ventricular models (Grandi et al., 2011). Atrial electrophysiology
is simulated by adopting several ion current functions in
part based on the findings of studies that reported the
protein expression but not function (Wang et al., 1996).
Furthermore, some parameters regarding functional ion
channel properties are derived from single references, since
experimental data from human atrial versus ventricular
myocytes is sparse.
Occurrence of whole-heart arrhythmias is even more complex
than basic cellular mechanisms of arrhythmia, since its initiation
depends on the stochastic coincidence of cellular arrhythmic
events in relation to the regular heart beat. The occurrence and
proarrhythmic significance of afterdepolarizations in isolated
cardiomyocytes differs from those of cardiomyocytes that are
embedded within the myocardial syncytium. Neighboring
cardiomyocytes, coupled via gap junctions, might serve
as a current-sink and thus counterbalance proarrhythmic
alterations of the membrane potential of a single myocyte,
which reduces the probability for a sAP to occur. Thus,
depolarization of a critical number of adjacent cardiomyocytes
is required to initiate an action potential on the multicellular
level (Rubart and Zipes, 2005). Furthermore, the likelihood
for initiation of sustained whole-heart arrhythmia does not
only depend on the mere number of premature ventricular
complexes (PVCs), but also on the timing of the PVC in
relation to the prior heartbeat as reflected in the typical
short-long-short initiation pattern of torsade-de-pointes
tachycardias (Kay et al., 1983) or its short-coupled variant
(Leenhardt et al., 1994). Beyond the initiation of whole-
heart arrhythmia, its perpetuation is even more complex and
underlies a multitude of factors including the anatomical
structure, pathophysiological alterations like myocardial scars
and the influence of antiarrhythmic drug or catheter-based
therapy.
Limitations
Experiments were conducted at room temperature. Thus,
functional parameters may differ, when these experiments are
performed at physiological temperatures. The current study
was performed on cardiomyocytes isolated from a non-diseased
mouse model. It is possible that remodeled atrial cardiomyocytes
from certain disease-models are not protected against the
occurrence of EADs and DADs. However, especially murine
models of atrial fibrillation are very diverse in showing shortened,
unchanged or even prolonged APDs as a reflection of a
heterogeneous underlying electrophysiology (Riley et al., 2012)
and thus may not always reflect the pathophysiology of human
atrial fibrillation where action potentials are usually prolonged.
Consequently, every model should be evaluated individually
regarding its validity and limitations.
CONCLUSION
Taken together, we have demonstrated that the manifestation
of proarrhythmic afterdepolarizations like EADs and the
development of sAPs from DADs differs between atrial and
ventricular myocytes in mice. This has to be considered when
using murine models for translational research particularly
with regard to atrial arrhythmia like atrial fibrillation. When
using other animal, in vitro or computational models, we
should critically scrutinize the underlying electrophysiological
features and other fundamental aspects of the cell types before
transferring findings derived from the ventricular level to atrial
level, especially with regard to arrhythmia.
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